000950 重藥控股
按盤價 
5.250 +0.050 (+0.962%)
5.250 +0.050 (+0.962%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.186 | 3.383 | 2.511 | 5.713 | 9.303 |
| 總資產報酬率 ROA (%) | 0.379 | 0.582 | 0.435 | 1.035 | 1.782 |
| 投入資產回報率 ROIC (%) | 0.619 | 0.966 | 0.738 | 1.710 | 2.795 | 邊際利潤分析 |
| 銷售毛利率 (%) | 6.791 | 7.205 | 7.434 | 7.993 | 8.581 |
| 營業利潤率 (%) | 1.019 | 0.828 | 0.698 | 1.231 | 2.116 |
| 息稅前利潤/營業總收入 (%) | 1.847 | 1.710 | 2.038 | 2.893 | 3.784 |
| 淨利潤/營業總收入 (%) | 0.779 | 0.632 | 0.499 | 0.932 | 1.715 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 148.482 | 169.722 | 129.526 | 108.174 | 82.894 |
| 價值變動淨收益/利潤總額(%) | 33.120 | 61.384 | 73.422 | 32.878 | 20.079 |
| 營業外收支淨額/利潤總額(%) | 2.229 | -1.639 | -0.921 | 0.150 | 2.545 | 償債能力分析 |
| 流動比率 (X) | 1.186 | 1.218 | 1.303 | 1.272 | 1.198 |
| 速動比率 (X) | 0.985 | 1.004 | 1.077 | 1.072 | 1.004 |
| 資產負債率 (%) | 75.451 | 75.008 | 75.291 | 75.638 | 77.776 |
| 帶息債務/全部投入資本 (%) | 71.080 | 69.729 | 69.689 | 66.949 | 69.010 |
| 股東權益/帶息債務 (%) | 38.948 | 41.544 | 40.361 | 46.044 | 42.106 |
| 股東權益/負債合計 (%) | 22.855 | 23.219 | 22.579 | 23.358 | 23.946 |
| 利息保障倍數 (X) | 2.294 | 1.910 | 1.514 | 1.742 | 2.346 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 169.464 | 150.646 | 145.517 | 139.277 | 144.535 |
| 存貨周轉天數 (天) | 48.154 | 47.097 | 44.848 | 41.089 | 40.388 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
